ARCHIVES

Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Approves Avastin For Recurrent NSCLC

October 27, 2006

“Wild West” of Molecular Testing?: Caris Engaged in Aggressive Marketing, Improper Medicare Billing, Lawsuit Alleges

August 8, 2014

In Brief: Albert and Mary Lasker Foundation announce 2014 award winners

September 12, 2014

FIT More Effective Than gFOBT In All Colonoscopy Capacities

November 25, 2011

Kushner Forms BreastPac

June 17, 1988

Preventive Oncology Announcement Withdrawn For Modification

April 3, 1981